SPATA2CRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。SPATA2遺伝子サイレンサーは、SPATA2 CRISPR/Cas9ノックアウトプラスミドとSPATA2Double Nickaseプラスミドとして利用可能です。遺伝子活性化用のSPATA2CRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
SPATA2 CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
SPATA2 CRISPR/Cas9 KOプラスミド (h) | sc-406210 | h | Gene Knockout | GFP | 1 | ||
SPATA2 HDRプラスミド (h) | sc-406210-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
SPATA2 Double Nickaseプラスミド (h) | sc-406210-NIC | h | Gene Knockout | Puromycin | 1 | ||
SPATA2 Double Nickaseプラスミド (h2) | sc-406210-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
SPATA2 CRISPR/Cas9 KOプラスミド (m) | sc-435216 | m | Gene Knockout | GFP | 0 | ||
SPATA2 HDRプラスミド (m) | sc-435216-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
SPATA2 Double Nickaseプラスミド (m) | sc-435216-NIC | m | Gene Knockout | Puromycin | 0 | ||
SPATA2 Double Nickaseプラスミド (m2) | sc-435216-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
SPATA2L CRISPR/Cas9 KOプラスミド (h) | sc-414208 | h | Gene Knockout | GFP | 0 | ||
SPATA2L HDRプラスミド (h) | sc-414208-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
SPATA2L Double Nickaseプラスミド (h) | sc-414208-NIC | h | Gene Knockout | Puromycin | 0 | ||
SPATA2L Double Nickaseプラスミド (h2) | sc-414208-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
SPATA2L CRISPR/Cas9 KOプラスミド (m) | sc-429709 | m | Gene Knockout | GFP | 0 | ||
SPATA2L HDRプラスミド (m) | sc-429709-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
SPATA2L Double Nickaseプラスミド (m) | sc-429709-NIC | m | Gene Knockout | Puromycin | 0 | ||
SPATA2L Double Nickaseプラスミド (m2) | sc-429709-NIC-2 | m | Gene Knockout | Puromycin | 0 |
SPATA2 CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
SPATA2 CRISPR Activationプラスミド (h) | sc-406210-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
SPATA2 CRISPR Activationプラスミド (h2) | sc-406210-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
SPATA2 Lentiviral Activation Particles (h) | sc-406210-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
SPATA2 Lentiviral Activation Particles (h2) | sc-406210-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
SPATA2 CRISPR Activationプラスミド (m) | sc-435216-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2 CRISPR Activationプラスミド (m2) | sc-435216-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2 Lentiviral Activation Particles (m) | sc-435216-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2 Lentiviral Activation Particles (m2) | sc-435216-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2L CRISPR Activationプラスミド (h) | sc-414208-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2L CRISPR Activationプラスミド (h2) | sc-414208-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2L Lentiviral Activation Particles (h) | sc-414208-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2L Lentiviral Activation Particles (h2) | sc-414208-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2L CRISPR Activationプラスミド (m) | sc-429709-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2L CRISPR Activationプラスミド (m2) | sc-429709-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2L Lentiviral Activation Particles (m) | sc-429709-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
SPATA2L Lentiviral Activation Particles (m2) | sc-429709-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |